| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 08/04/2005 | US20050172363 Nematode PPPT-like sequences |
| 08/04/2005 | US20050172350 Identifying modulators of purine/pyrimidine phosphoribosyl transferase (PPPT) polypeptides; treating and preventing microorganismal infection in crop plants |
| 08/04/2005 | US20050172343 Astrocyte modulated genes and uses thereof |
| 08/04/2005 | US20050171342 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 08/04/2005 | US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 08/04/2005 | US20050171337 Soluble interleukin-1 receptor accessory molecule |
| 08/04/2005 | US20050171334 Disposable surface modified support to produce attached peptide, oligosaccharide or oligonucleotide; chromatography |
| 08/04/2005 | US20050171333 Lithium chloride/bromide, alcohol (ethanol/methanol), and trisodium citrate; solid phase synthesis; deoxyribonucleases |
| 08/04/2005 | US20050171048 Nuclease activity resistance; mixed sequence oligonucleotides containing purine or pyrimidine base in beta anomeric configuration; drug delivery agents; targeting specific DNA and/or RNA sequences |
| 08/04/2005 | US20050171047 Immunostimulatory nucleic acid molecules |
| 08/04/2005 | US20050171044 Oligonucleotide compound and method for treating nidovirus infections |
| 08/04/2005 | US20050171040 Chemically synthesized double stranded molecules; hypercholesterolemia, hyperlipidemia, cardiovascular and cerebrovascular disorders, aortic stenosis, peripheral vascular disease, atherosclerosis |
| 08/04/2005 | US20050171039 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| 08/04/2005 | US20050171018 Novel polypeptide and gene encoding the same |
| 08/04/2005 | US20050170509 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery |
| 08/04/2005 | US20050170500 Methods for identifying risk of melanoma and treatments thereof |
| 08/04/2005 | US20050170467 Nucleic acid sequences for polypeptides that inhibit endothelial cell growth; PRO Polypeptides; homology to Fibroblast Growth Factor-8 (FGF-8); vectors, host cells, primers and probes |
| 08/04/2005 | US20050170465 Nucleotide sequences coding transport proteins for identifying modulators for prevention and treatment of cell proliferative, nervous system, skin and inflammatory disorders |
| 08/04/2005 | US20050170461 Identifying modulators which modify ligand protein binding for human pitutary and/or mouse pancreas-derived G protein-coupled receptorl treating nervous system and infectious disorders |
| 08/04/2005 | US20050170458 Inhibiting endothelial cell growth |
| 08/04/2005 | US20050170457 Novel recombinant proteins with N-terminal free thiol |
| 08/04/2005 | US20050170455 Novel prokineticin receptor isoforms and methods of use |
| 08/04/2005 | US20050170452 Method to engineer mammanlian-type carbohydrate structures |
| 08/04/2005 | US20050170427 For activated slides for preparing microarrays of nucleic acids; solid phase synthesis |
| 08/04/2005 | US20050170423 Systems and methods for transgenic and targeted mutagenesis screening |
| 08/04/2005 | US20050170404 Modified human growth hormone polypeptides and their uses |
| 08/04/2005 | US20050170396 Using monoclonal antibodies to determine concentration of preferential membrane bound receptor in cancer cells; immunoassay |
| 08/04/2005 | US20050170388 Pyrimidine nucleobases |
| 08/04/2005 | US20050170380 Ribosomal protein for treatment, diagnosis and prevention of cell proliferative, atherosclerotic and nervous system disorders |
| 08/04/2005 | US20050170377 Anticode oligomer for prevention and treatment of cell proliferative disorders; antitumor, antisense, antiproliferative agents |
| 08/04/2005 | US20050170370 Microarray comprising immobilized primers for monitoring RNA expression; transcrptional analysis |
| 08/04/2005 | US20050170368 Tumor-associated antigenic target polypeptides for use as tools in treatment of cell proliferative disorders; antitumor and/or antiproliferative agents |
| 08/04/2005 | US20050170367 For polymerase screening |
| 08/04/2005 | US20050170349 A purified polypeptide comprising a splice variant of AMP-activated kinase; a nucleic acid and expression vector; bioassay for modulators; antibodies for the polypeptide; improved metabolic regulation |
| 08/04/2005 | US20050170348 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 08/04/2005 | US20050170340 Solid support comprising a plurality of immobilized, positionally distinguishable, multi-subunit sequence specific reagents for use in characterization and classification of biological samples; immunoaffinity chromatography |
| 08/04/2005 | US20050170337 Nucleotide sequences coding coiled-coil viral oligomer for identifying modulator for treatment and prevention of hepatitis; viricides |
| 08/04/2005 | US20050170281 Triplet states; exposure to electromagnetic radiation; DNA biochips; solid phase synthesis; kits |
| 08/04/2005 | US20050169942 Novel DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain for production of therapeutics |
| 08/04/2005 | US20050169914 Novel functions for decay accelerating factor (DAF) in inflammation |
| 08/04/2005 | US20050169905 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 08/04/2005 | US20050169904 biodrug fusion protein comprising active mitochondrial protein or peptide, a mitochondrial membrane-permeant peptide and linking to a mitochondrial targeting sequence; targeting sequence is cleaved within the mitochondrial matrix, and not cleaved within the cellular cytoplasm; mitochondrial disorders |
| 08/04/2005 | CA2554618A1 Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound |
| 08/04/2005 | CA2553883A1 Anti-cancer antibodies with reduced complement fixation |
| 08/04/2005 | CA2553828A1 Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing |
| 08/04/2005 | CA2553257A1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 08/04/2005 | CA2553221A1 Folate conjugates and complexes |
| 08/04/2005 | CA2550551A1 Fusion polypeptides capable of activating receptors |
| 08/03/2005 | EP1559791A2 Detection and quantification of siRNA on micro-arrays |
| 08/03/2005 | EP1559785A1 Oligo- or polynucleotides for achieving RNA interference in mammalian cells |
| 08/03/2005 | EP1559784A2 Rapid extraction of RNA from cells and tissues |
| 08/03/2005 | EP1559737A1 Methods for producing low binding surfaces |
| 08/03/2005 | EP1559726A2 Growth differentiation factor-10 |
| 08/03/2005 | EP1558767A2 Compositions and methods for identifying plants having increased tolerance to imidazolinone herbicides |
| 08/03/2005 | EP1558766A2 Use of a33 antigens and jam-it |
| 08/03/2005 | EP1558757A1 Gas jet process and apparatus for high-speed amplification of dna |
| 08/03/2005 | EP1558748A2 Cell lysis compositions, methods of use, apparatus, and kit |
| 08/03/2005 | EP1558729A2 Rapidly degraded reporter fusion proteins |
| 08/03/2005 | EP1558631A2 Methods and compositions for diagnosing and treating companion animal cancer |
| 08/03/2005 | EP1558278A2 Production of homotrimeric fusion proteins |
| 08/03/2005 | EP1558276A2 Flaviviris fusion inhibitors |
| 08/03/2005 | EP1558085A1 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer |
| 08/03/2005 | EP1237900A4 Subunit optimized fusion proteins |
| 08/03/2005 | EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 08/03/2005 | EP0742834B2 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
| 08/03/2005 | CN1650030A Surface modification, linker attachment, and polymerization methods |
| 08/03/2005 | CN1650011A Methods and compositions for treating neoplasms by ERBB3 |
| 08/03/2005 | CN1649935A Monomers containing polyoxyalkylenes and polymer supports therefrom |
| 08/03/2005 | CN1649890A Anti-protozoal vaccine |
| 08/03/2005 | CN1649889A Process for preparing oligonucleotides |
| 08/03/2005 | CN1648249A Small molecular interference ribonucleic acid for inhibiting SARS virus gene expression |
| 08/03/2005 | CN1213069C Growth promoting factor and its prepn and use |
| 08/03/2005 | CN1213056C Structure and uses of autisense oligodeoxynucleotide for treating thrombus disease |
| 08/02/2005 | US6924367 Method of modulating tissue growth using Frzb Protein |
| 08/02/2005 | US6924366 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 08/02/2005 | US6924365 Optimized messenger RNA |
| 08/02/2005 | US6924363 use in the separation and recovery of recombinant polypeptides from the cell due to the difference in densities between oil bodies and aqueous solutions |
| 08/02/2005 | US6924137 virus is propagated in culture media at a cultivation temperature below 37 degrees C., wherein the chordopoxvirus is selected from Avipoxvirus and modified vaccinia virus Ankara |
| 08/02/2005 | US6924135 DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof |
| 08/02/2005 | US6924121 Sperm specific proteins |
| 08/02/2005 | US6924103 Screening method for gene variation |
| 08/02/2005 | US6924098 Nucleic acid ladders |
| 07/28/2005 | WO2005068661A1 Methods and compositions for regulating cell cycle checkpoints |
| 07/28/2005 | WO2005068646A1 Methods for the protein production and purification of soluble recombinant polypeptides |
| 07/28/2005 | WO2005068626A1 Methods for nucleic acid isolation and kits using a microfluidic device and sedimenting reagent |
| 07/28/2005 | WO2005068618A1 Polynucleotides encoding novel ubch10 polypeptides and kits and methods using same |
| 07/28/2005 | WO2005068486A1 Heterodinucleoside phosphate dimer |
| 07/28/2005 | WO2005067960A1 HIV gp41 HR2-DERIVED SYNTHETIC PEPTIDES, AND THEIR USE IN THERAPY TO INHIBIT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS |
| 07/28/2005 | WO2005067699A1 Methods of expressing heterologous protein in plant seeds using monocot non seed-storage protein promoters |
| 07/28/2005 | WO2005067692A2 Detection and quantification of analytes in solution using polymers |
| 07/28/2005 | WO2005067648A2 Multiplex spatial profiling of gene expression |
| 07/28/2005 | WO2005067643A2 Determination of hepatitis c virus genotype |
| 07/28/2005 | WO2005067491A2 Toxin complex proteins and genes from xenorhabdus bovienii |
| 07/28/2005 | WO2005067478A2 Recombinant icosahedral virus like particle production in pseudomonads |
| 07/28/2005 | WO2005067437A2 Methods and compositions for in vitro and in vivo use of parallel stranded hairpins and triplex structures as nucleic acid ligands |
| 07/28/2005 | WO2005054438A3 Nucleic acid molecules containing recombination sites and methods of using the same |
| 07/28/2005 | WO2005045062A3 Gene expression and polymorphisms associated with lung cancer |
| 07/28/2005 | WO2005042581A3 Modified anti-cd52 antibody |
| 07/28/2005 | WO2005035545A3 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 07/28/2005 | WO2005027710A3 Methods for identifying subjects at risk of melanoma and treatments thereof |